Here’s an innovation in the treatment for prostate cancer from a Canadian study. It says a significant proportion of men newly diagnosed with the disease can be safely managed with “active surveillance” instead of undergoing radical treatment that can cause a variety of unpleasant side-effects.
Active surveillance means frequent monitoring of PSA levels and periodic biopsies to make sure the cancer hasn’t become more aggressive and spread.
The long-term study found that men with low-grade, slow-growing prostate cancer who were managed with active surveillance had a 10-year survival rate of more than 97 per cent, and an overall survival rate of almost 80 per cent.
The researchers figure about 40 per cent of newly diagnosed men will be candidates for active surveillance. They estimate that this year more than 25,000 Canadian men will find out they have prostate cancer.